| Literature DB >> 30197104 |
J R Winter1, L E Green2.
Abstract
Clinical trials have demonstrated that sheep with footrot treated with parenteral and topical antibiotics without foot trimming (treatment A), cure faster than sheep treated with foot trimming and topical antibiotics (treatment B). We investigated how key players in the UK sheep industry recommended treating footrot, and tested whether reviewing the evidence surrounding treatment of footrot changed their beliefs. Eight key players attended a workshop to investigate their current practices, and their perceived efficacy of treatments, using probabilistic elicitation. At the start of the study, all participants recommended use of antibiotic injection but only four recommended not foot trimming feet with footrot. Initial beliefs in the difference in cure rate within five days of treatment ranged from 30 to 97% in favour of treatment A (true difference 60%); this heterogeneity reduced after reviewing the evidence. Participants who believed the cure rate differed by >60% over-estimated the cure rate of treatment A whilst participants who believed the difference was <60% over-estimated the efficacy of treatment B. During discussions, participants stated that parenteral antibiotics had always been recommended as a treatment for footrot but that the new research clarified when to use them. In contrast, it was highly novel to hear that foot trimming was detrimental to recovery, and key players and farmers are taking longer to accept this evidence. Three months after the workshop, two participants stated that they now placed greater emphasis on rapid individual antibiotic treatment of lame sheep and one was no longer recommending trimming feet.Entities:
Keywords: Evidence base; Expert elicitation; Footrot treatment efficacy; Key players; Sheep
Mesh:
Year: 2018 PMID: 30197104 PMCID: PMC6143487 DOI: 10.1016/j.tvjl.2018.07.009
Source DB: PubMed Journal: Vet J ISSN: 1090-0233 Impact factor: 2.688
The roles of each participant in the sheep industry.
| Participant | Role | Farmed sheep |
|---|---|---|
| 1 | Knowledge transfer | Yes |
| 2 | Consultant | Yes |
| 3 | Vet and consultant | No |
| 4 | Consultant | No |
| 5 | Knowledge transfer | No |
| 6 | Consultant | Yes |
| 7 | Vet and consultant | Yes |
| 8 | Consultant and breeder | Yes |
The number of participants in our study who currently gave each piece of advice to all clients, and the number of participants who would consider each piece of advice to be part of ‘reference standard’ care.
| Advice | Number of participants currently giving this advice to all clients | Number of participants who considered this advice part of ‘reference standard’ care |
|---|---|---|
| Antibiotic injection | 8 | 8 |
| Vaccinate with Footvax | 5 | 6 |
| Treat promptly | 4 | 4 |
| Foot spray | 4 | 4 |
| Do not trim feet | 4 | 5 |
| Segregate sheep with footrot | 4 | 5 |
| Cull repeatedly lame ewes | 4 | 6 |
| Mark ewes | 3 | 3 |
| Record ear tag number | 2 | 2 |
| Check cause of lameness | 2 | 2 |
| Re-treat sheep later if necessary | 2 | 2 |
| Inspect sheep after treating | 1 | 1 |
| Cull sheep with chronically infected or misshapen feet | 1 | 1 |
| Quarantine new sheep | 2 | 4 |
| Footbath new sheep | 1 | 3 |
| Check the feet of all new sheep | 1 | 1 |
| Footbath after gathering | 1 | 2 |
| Avoid gathering sheep | 1 | 3 |
| Inspect the feet of the entire flock | 0 | 1 |
| Avoid buying replacement ewes with poor foot conformation | 0 | 1 |
Fig. 1Fitted Gaussian probability density functions of eight participants, before and after a review of the evidence on treatments for footrot. Positive responses favoured ‘injection and spray’ over ‘trim and spray’. Values for the fitted hyperparameters (mean and standard deviation) are shown in Table 3. The published literature currently supports a difference in cure rates of approximately 60%.
Hyperparameters for the fitted Gaussian probability distributions.
| Participant | Before evidence review | After evidence review | Change in fitted parameters | |||||
|---|---|---|---|---|---|---|---|---|
| θd cure rate | SD | 95% CI | θd cure rate | SD | 95% CI | Mean | SD | |
| 1 | 90.0 | 3.8 | 83–97 | 62.5 | 4.6 | 53–72 | −27.5 | +0.9 |
| 2 | 76.9 | 3.5 | 70–84 | 77.5 | 3.6 | 70–85 | +0.6 | +0.1 |
| 3 | 90.0 | 3.8 | 83–97 | 90.0 | 3.8 | 83–97 | 0.0 | 0.0 |
| 4 | 68.8 | 9.6 | 50–88 | 62.5 | 3.9 | 55–70 | −6.3 | −5.6 |
| 5 | 58.9 | 6.2 | 47–71 | 72.1 | 6.8 | 59–85 | +13.3 | +0.6 |
| 6 | 81.7 | 6.6 | 69–95 | 67.5 | 2.4 | 63–72 | −14.2 | −4.2 |
| 7 | 38.1 | 4.1 | 30–46 | 60.0 | 1.2 | 58–62 | +21.9 | −2.9 |
| 8 | 57.5 | 9.8 | 38–77 | 63.1 | 7.8 | 48–78 | +5.6 | −2.0 |
θd, difference in cure rates; SD, standard deviation; CI, credible interval.
Elicited values for the cure rate by treatments A (inject and spray) and B (trim and spray) and the difference between the two estimated cure rates, before and after the review of the evidence, and the change in estimates after the review of the evidence.
| Part | Before evidence review | After evidence review | Change in diff in cure rates | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Treatment A | Treatment B | Diff | Treatment A | Treatment B | Diff | ||||||
| Cure rate θ1 | 95% CI | Cure rate θ2 | 95% CI | θ1 Cure rate | 95% CI | θ2 Cure rate | 95% CI | (θ1 − θ2)after − (θ1 − θ2)before | |||
| 1 | 95 | 80–100 | 40 | 30–45 | 55 | 70 | 60–75 | 10 | 5–15 | 60 | +5 |
| 2 | 80 | 60–90 | 10 | 5–20 | 70 | 80 | 60–90 | 10 | 5–20 | 70 | 0 |
| 3 | 75 | 60–90 | 20 | 0–40 | 55 | 75 | 60–90 | 15 | 0–30 | 60 | +5 |
| 4 | 75 | 40–90 | 10 | 0–50 | 65 | 70 | 60–80 | 10 | 0–20 | 60 | −5 |
| 5 | 80 | 60–95 | 30 | 25–45 | 50 | 90 | 70–95 | 25 | 15–30 | 65 | +15 |
| 6 | 90 | 60–100 | 10 | 0–30 | 80 | 75 | 60–100 | 10 | 0–30 | 65 | −15 |
| 7 | 75 | 70–85 | 30 | 15–35 | 45 | 72 | 70–75 | 11 | 10–20 | 61 | +16 |
| 8 | 93 | 85–100 | 35 | 20–40 | 58 | 90 | 70–99 | 35 | 20–50 | 55 | −3 |
Part, participant; θ1, injection and spray; θ2, trim and spray; Diff, difference; CI, credible interval.
Fig. 2Eight participants probability density functions fitted to the raw elicited data from each participant. Positive responses favoured ‘injection and spray’ over ‘trim and spray’. Values for the fitted hyperparameters (mean and standard deviation) are shown in Table 3.